0000912057-17-000233 Sample Contracts

April 24th, 2014

First Amendment of License Agreement • August 4th, 2017 • OptiNose, Inc. • Pharmaceutical preparations

• Contract Type
  First Amendment of License Agreement
• Filed
  August 4th, 2017
• Company
  OptiNose, Inc.
• Industry
  Pharmaceutical preparations

This letter confirms our understanding and agreement with respect to the assignment by OptiNose to Avanir of IND No. 110090. Unless otherwise defined in this letter, all initially capitalized terms used in this letter shall have the meanings given to such terms in the Agreement.

AMENDMENT TO LICENSE AGREEMENT

License Agreement • August 4th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  License Agreement
• Filed
  August 4th, 2017
• Company
  OptiNose, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This AMENDMENT TO LICENSE AGREEMENT (this “Amendment”) is entered into on August 6, 2015 by and between OPTINOSE AS, a Norwegian corporation, company registration number 982483131 (“OptiNose”), with its principal place of business at Tore Hals Mejdells vei 7, 0751 Oslo, Norway, and its postal address at Pb 288 Roa, 0702 Oslo, Norway, and AVANIR PHARMACEUTICALS, INC., a Delaware corporation (“Avanir”), with offices at 30 Enterprise, Suite 400, Aliso Viejo, CA 92656, U.S.A. OptiNose and Avanir are sometimes referred to herein as a “Party” and collectively as the “Parties.”